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Germline mutations in many of the genes that are involved in
homologous recombination (HR)-mediated DNA double-strand
break repair (DSBR) are associated with various human genetic
disorders and cancer. RAD51 and RAD51 paralogs are important
for HR and in the maintenance of genome stability. Despite the
identiﬁcation of ﬁve RAD51 paralogs over a decade ago, the molec-
ular mechanism(s) by which RAD51 paralogs regulate HR and
genome maintenance remains obscure. In addition to the known
roles of RAD51C in early and late stages of HR, it also contributes
to activation of the checkpoint kinase CHK2. One recent study iden-
tiﬁes biallelic mutation in RAD51C leading to Fanconi anemia-like
disorder. Whereas a second study reports monoallelic mutation in
RAD51C associated with increased risk of breast and ovarian cancer.
These reports show RAD51C is a cancer susceptibility gene. In this
review, we focus on describing the functions of RAD51C in HR, DNA
damage signaling and as a tumor suppressor with an emphasis on
the new roles of RAD51C unveiled by these reports.
Introduction
Homologousrecombination(HR),afundamentalcellularprocesscon-
served in all organisms, maintains genome integrity by repairing en-
dogenous and exogenous DNA double-strand breaks (DSBs). DSBs
generated during DNA replication are preferentially repaired by sister
chromatid recombination, an HR pathway that utilizes neighboring
sister chromatid as a template (1–3). HR dysfunction may cause ab-
errant genetic rearrangements and genomic instability, resulting in
chromosomal translocations, deletions, ampliﬁcations or loss of het-
erozygosity (LOH). Indeed, several cancer susceptibility genetic dis-
eases such as ataxia telangiectasia, Nijmegen breakage syndrome,
Bloom syndrome and Fanconi anemia (FA), which are due to lack
of single genes show hyper- or hypo-recombination phenotype
(4–10). Furthermore, germline mutations in BRCA1 and BRCA2,
which are known to regulate HR, cause hereditary breast and ovarian
cancers, implying a crucial role of HR, and the genes that regulate HR
in cancer prevention (11–13).
Replication of genome is hampered when the replication fork en-
counters lesions on DNA, resulting in stalling or collapsing of forks.
HR plays a key role in the repair of double-strand break repair (DSBR)
and daughter strand gaps that arise during replication and the restart of
replication forks, ensuring duplication of the genome and cell division
(6,14).Failureinthestabilization of stalled forks or inthe processing of
replication forks for restart could result in the accumulation of muta-
tions and chromosomal aberrations (CAs) (15,16). Indeed, a variety of
human genetic disorders associated with cancer are caused by muta-
tions in the genes that protect genome integrity during DNA replication
(6,17–19). Furthermore, HR has been known to play an important role
in the repair of DNA interstrand cross-links (ICLs) in collaboration
with nucleotide excision repair and translesion synthesis (20–22). HR
deﬁciency may divert cells to alternative, error-prone repair pathways,
including non-homologous end joining and single-strand annealing.
These error-prone pathways signiﬁcantly contribute to genome insta-
bility in the form of CAs, insertions or deletions and subtle mutations.
RAD51 and RAD51 paralogs in HR
The central steps of HR involve processing of DSB ends, homology
search and strand invasion. RAD51 protein, a eukaryotic ortholog
of Escherichia coli RecA, polymerizes onto single-stranded DNA
(ssDNA) to form a helical nucleoprotein ﬁlament (23,24). The pre-
synaptic ﬁlament of RAD51 engages in homology search and invades
homologous duplex DNA to generate D-loop structure (5,25). Syn-
thesis initiated from the invading strand results in D-loop extension.
This recombination intermediate is thought to be channeled into two
subpathways, DSBR or synthesis-dependent strand annealing (SDSA)
(Figure 1) (26–28). In DSBR, the extended D-loop can be captured
by a second end of DSB to form a double Holliday junction (HJ).
The double HJ can be resolved by a junction speciﬁc endonuclease
to generate crossover or non-crossover products. Double HJ can also
be resolved to non-crossover products by the concerted action of
helicases and topoisomerases (29–31). Crossover-associated recom-
bination is essential for proper chromosome disjunction in meiotic
cells. In contrast, this pathway is highly suppressed in somatic cells as
crossovers can lead to LOH and chromosome rearrangements
(24,27,32–34). In SDSA, however, the nascent strand displaced
from the D-loop pairs with second end of the DSB to resolve as
a non-crossover product (Figure 1) (26,35,36).
The nucleation of RAD51 protein onto ssDNA is impeded by the
heterotrimeric replication protein A (RPA) protein, an abundant nu-
clear protein that binds to ssDNA with high afﬁnity (5,24). Genetic
and biochemical studies have identiﬁed recombination mediators in
Saccharomyces cerevisiae.These recombination mediators counteract
the inhibitory action of RPA and assist RAD51 polymerization onto
ssDNA (5,27,32). Biochemical studies show that addition of catalytic
amounts of RAD52 results in several fold stimulation of RAD51
recombinase activities by alleviating the inhibitory action of RPA
(37,38), suggesting that mediator function of RAD52 is critical for
RAD51-mediated HR (5,24). The S.cerevisiae RAD55 and RAD57
proteins are considered as RAD51 paralogs and these protein share
20–30% sequence identity with RAD51. These RAD51 paralogs pos-
sess a conserved nucleotide triphosphate-binding motif, form a stable
heterodimer and bind ssDNA but exhibit weak adenosine triphospha-
tase activity (27,32,39). RAD55 and RAD57 proteins stimulate
RAD51-mediated homologous pairing and strand exchange in vitro
(40). Furthermore, overexpression of RAD51 can rescue ionizing
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ing that RAD55–RAD57 complex plays an important role in forma-
tion or stabilization of the RAD51 ﬁlament (32).
The genome-wide search for S.cerevisiae RAD52 epistasis group
genes in human and mouse resulted in the identiﬁcation of RAD51,
RAD52, RAD54 and RAD54B (25,27,32,33). The human RAD51
(hRAD51) is highly conserved to that of ScRAD51 and display
68% amino acid identity. In contrast, human RAD52 and RAD54
are less conserved. Human RAD52 lacks a recombination mediator
function (39), but human RAD54 physically interacts with RAD51
and stimulates its activity (43,44). Biochemical studies have shown
that RAD54 functions at all three stages of HR; presynapsis, synapsis
and postsynapsis (45–47). Notably, orthologs of S.cerevisiae RAD55
and RAD57 have not been identiﬁed in mammalian cells. An ap-
proach using human genes that complement IR sensitivity of mutant
hamster cells was used to identify mammalian genes that are essential
for HR. Using this approach, human XRCC2 and XRCC3, which com-
plementsIRsensitivityofirs1andirs1SF hamstercells,werediscovered
as members of a RAD51-like family of genes (48,49). By searching the
human genome database for sequence similarity to RAD51, additional
mammalian RAD51 paralogs; RAD51B, RAD51C and RAD51D were
discovered (50–52). Sequence analysis reveals that mammalian RAD51
paralogs display 20–30% identity with hRAD51 and the homology is
mainly restricted to adenosine triphosphate-binding motifs (53).
Early studies with Chinese hamster irs1 and irs1SF cells defective
in XRCC2 and XRCC3, respectively, revealed that these cells were
sensitive to DNA damaging agents such as IR, ultraviolet light, ethyl
methanesulfonate and camptothecin. Interestingly, these mutants were
extremely sensitive to ICL agent mitomycin C (MMC) (48,54–56).
Both mutants exhibited high rates of spontaneous and IR-induced
CAs, defective chromosome segregation (48,57), reduced RAD51
nuclear foci formation and decreased frequency of DSBR by
HR (58–61). In addition, chicken cells deﬁcient in RAD51B, C and
D exhibited hypersensitivity to DNA damaging agents, high spontane-
ous CAs and reduced rate of sister chromatid exchange (62,63). Fur-
thermore, Chinese hamster cells defective in RAD51C (irs3 and
CL-V4B) and RAD51D also displayed a phenotype similar to that of
irs1andirs1SFcells(64–66).GeneticknockoutsofRAD51B,RAD51C,
RAD51D and XRCC2 in mouse cause early embryonic lethality
(67–70), implying a crucial role ofRAD51 paralogs inthe maintenance
of genome integrity during development. Interestingly, DT40 cells de-
fective in xrcc3/rad51d, in which both the BCDX2 and CX3 complexes
are impaired, exhibit higher sensitivity to camptothecin and cisplatin
than rad51b/rad51d-double mutants, in which only BCDX2 complex
is dysfunctional (71). These observations clearly suggest that RAD51
paralogs have non-redundant functions in HR and genome maintenance.
RAD51C recombination functions
Biochemical and two-hybrid analyses indicate that RAD51 paralogs
form two distinct complexes: the RAD51B/RAD51C/RAD51D/
XRCC2 (BCDX2) complex and the RAD51C/XRCC3 (CX3) com-
plex (56,72). Interestingly, RAD51C is part of both complexes.
BCDX2 complex proteins have been shown to bind single- and
double-stranded DNA and hydrolyze adenosine triphosphate (73–76).
Homologous pairing activity has been reported for puriﬁed CX3
and XRCC2–RAD51D subcomplex (74,77). Furthermore, the BC
heterodimer has been shown to function as a mediator in RAD51-
and RPA-catalyzed strand exchange (73). These results suggest a role
for RAD51 paralogs in the initial stages of recombination, assisting
RAD51-mediated HR.
Recent genetic and biochemical studies indicate a possible role of
RAD51 paralogs in the late stages of HR. RAD51B and BCDX2
complex have been independently shown to bind speciﬁcally to HJ
and Y-junction substrates (78,79). Although a puriﬁed complex con-
taining RAD51C and XRCC3 from HeLa cells has been reported to
promote HJ branch migration and resolution, a similar activity was
lackingforpuriﬁedrecombinantRAD51C(80).Interestingly,RAD51C
sequences do not show any nuclease domain, suggesting that perhaps
anucleaseassociatedwithRAD51CcouldbeinvolvedinHJresolution.
Indeed, a recent study showed that puriﬁed GEN1 nuclease from HeLa
cells possesses an HJ resolvase activity (81). It will be interesting
to study whether RAD51C interacts with GEN1 or any other nuclease
to promote HJ resolution. Using sister chromatid recombination re-
porter, gene conversions have been measured in hamster cells lacking
RAD51 paralogs. Strikingly, cells defective with RAD51C, XRCC2
and XRCC3 exhibit increased frequency of long-tract gene conversion
events, suggesting an important function of RAD51 paralogs in resolv-
ing recombination intermediates (34,82–84). It is possible that RAD51C
might promote SDSA type of repair to suppress long-tract gene con-
version by displacing the nascent strand from the sister chromatid
(Figure 1). Helicases are implicated in this kind of a function (85,86).
However, RAD51C lacks any helicase motif, suggesting that RAD51C
in part with an unidentiﬁed helicase could be involved in the SDSA type
of DSBR. Interestingly, RAD51D has been shown to physically interact
with BLM helicase and, the puriﬁed RAD51D–XRCC2 complex stim-
ulates BLM-mediated HJ resolution (87). It is probably that RAD51C
may interact with BLM or any other helicase and facilitate SDSA to
suppress long-tract gene conversion. However, further investigation is
required to test this hypothesis.
Fig. 1. Alternative mechanisms of DNA DSBR by HR. DSBs can be
repaired by two alternative pathways of HR such as SDSA and DSBR.
In both the pathways, DSB ends are processed by nucleolytic resection to
generate 3# ssDNA, which serves as a substrate for HR machinery to engage
in homologous search and strand invasion. DNA synthesis will be initiated
from the invaded strand in D-loop structures. In the SDSA pathway, the
nascent strand will be displaced from the D-loop and anneals to the second
end of the broken DNA, followed by gap ﬁlling and ligation DSBR is
completed. In the DSBR pathway, extension of D-loop by nascent strand
synthesis captures the second end to generate double-HJ structures. After the
gap repair and ligation, HJs are resolved by resolvases to result in either
non-crossover (black triangles) or crossover products (gray triangles).
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2032RAD51 paralogs have been reported to have specialized roles:
RAD51C in checkpoint activation by checkpoint kinase CHK2 (88)
and in maintaining centrosome integrity (89), RAD51D in telomere
maintenance (90), XRCC3 in the restart of stalled replication forks
(91), in replication fork progression (92) and telomere maintenance
by T-loop deletion (93). Interestingly, recent studies show that
RAD51C has novel functions; in the DNA damage response, in the
repair of ICLs possibly in collaboration with FA proteins and ﬁnally
as a cancer susceptibility gene. We discuss these novel and important
functions of RAD51C in the following section.
Role of RAD51C in DNA damage responses
In response to DSBs and other types of DNA damage, eukaryotic cells
have evolved to induce a complex network of DNA damage signaling,
which coordinate cell cycle checkpoint with DNA repair to maintain
genome stability. Ataxia-telangiectasia mutated (ATM) and ATM and
RAD3-related (ATR) kinases are key players in the DNA damage sig-
naling mechanism. ATM and ATR mutation causes defective response
to DNA damage, resulting in disorders, such as ataxia-telangiectasia and
ATR-Seckel syndrome, respectively, which are characterized by devel-
opmental defects, DNA damage sensitivity and cancer predisposition
(8,94–96).
In a recent study, Badie et al. (88) show that RAD51C localizes to
the sites of DNA damage before and independently of RAD51, sup-
porting that RAD51C has a role in the early stages of HR. Interest-
ingly, RAD51C accumulation at the sites of DSBs was dependent on
ATM, NBS1 and RPA, suggesting that processing of DSB ends is
a prerequisite for RAD51C localization and downstream activation
of HR through RAD51 assembly. Strikingly, their studies show that
RAD51C is required for phosphorylation of CHK2 by ATM, which is
required for checkpoint activation. Defective CHK2 activation causes
progression of cells into G2/M phase in response to DNA damage
(88). These results reveal a novel function of RAD51C in signaling
and checkpoint function. However, whether RAD51C is a target of
ATM phosphorylation remains to be tested. ATM/ATR target sub-
strates possess conserved SQ/TQ motifs and RAD51C sequence con-
tains TQ motifs, indicating that RAD51C is a possible substrate
for ATM/ATR kinase (Figure 2). The RAD51C-interacting partner
XRCC3 is also required for CHK2 activation (88). However, whether
dynamic interaction of RAD51C and XRCC3 is essential for CHK2
phosphorylation and checkpoint activation remains to be studied.
The checkpoint kinase CHK2 transduces DNA damage signaling
from ATM and regulates cell cycle progression, DNA repair and
apoptosis or senescence (97). There is evidence that CHK2 controls
DNA repair; following activation by ATM, CHK2 phosphorylates
various downstream effectors including BRCA1 (98). CHK2-dependent
BRCA1 S988 phosphorylation regulates DSBR by HR (99), suggest-
ing a direct role of CHK2 in DNA repair. The expression of BRCA2
and XRCC1 that are required for HR and base excision repair, re-
spectively, is controlled by FOXM1 transcription factor, and the
stability of FOXM1 transcription factor increases upon phosphory-
lation by CHK2, suggesting that DNA damage-induced CHK2 acti-
vation controls BRCA2 and XRCC1 expression (100). It will be
interesting to test whether any of these CHK2-dependent functions
are affected by RAD51C deﬁciency. In addition, whether RAD51C
has any role in CHK2-dependent apoptosis or senescence remains to
be investigated.
Germline mutations in p53, ATM, ATR, BRCA1 and BRCA2 whose
products are known to regulate DNA repair and checkpoint functions
leads to genetic instability disorders and various types of cancer (101).
Similarly, mutations in CHK2 have been identiﬁed in familial breast
and prostate cancer (95,102). There are also reports which indicate
that germline mutation in CHK2 increases the risk of developing
ovarian, colorectal, kidney, thyroid and bladder cancer, suggesting
that CHK2 is a multiorgan cancer susceptibility gene (97). Interest-
ingly, germline mutations in RAD51C have been identiﬁed recently
in FA-like disorder and breast and ovarian cancer, indicating that
RAD51C is a cancer susceptibility gene (103,104). Since CHK2
activation is dependent on RAD51C, it will be interesting to study
whether RAD51C is also mutated invarious types of cancer associated
with CHK2 mutation.
RAD51C as a novel gene in the FA pathway
FA is a rare autosomal and X-linked recessive chromosome instability
syndrome characterized by congenital abnormalities, progressive
bone marrow failure, predisposition to acute myelogenous leukemia
and malignancies (105–107). The hallmarks of FA cells are genome
instability and extreme sensitivity to DNA ICL agents, such as MMC,
diepoxybutane and cisplatin (107). FA is a genetically heterogeneous
disorder, and complementation analyses by cell fusion experiments
revealed at least 13 complementation groups (A, B, C, D1, D2, E, F,
G, I, J,L,M and N) (108,109).ManyFAgenes codeforsubunitsof FA
core complex (FANCA, B, C, E, F, G, L and M), and one of the main
functions of this complex is to monoubiquitinate FANCD2 and FAN-
CI, which is essential for DNA repair (110,111). FANCL has been
shown to be ubiquitin ligase responsible for monoubiquitination of
FANCD2 and FANCI (108,110,112,113). Interestingly, three of the
FA genes, FANCD1, FANCN and FANCJ,have been found to be breast
cancer susceptibility (BRCA) genes BRCA2, PALB2 and BACH1, re-
spectively (109,114–119). FA proteins and another well-known breast
cancer susceptibility protein BRCA1 cooperate in a common path-
way of DNA damage response and repair of ICLs (111). FA proteins
are also known to have molecular and functional interaction with
proteins such as ATM, ATR, NBS1 and BLM, responsible for other
rare genetic instability syndromes ataxia telenagiectasia, Seckel syn-
drome, Nijmegen breakage syndrome and Bloom syndrome, respec-
tively (6,108).
Fig. 2. A model for the role of RAD51C in DSBR by HR, ICL repair and
checkpoint activation. (a) In response to DSBs, RAD51C localizes to DSBs
in an ATM/ATR-dependent manner. (b) RAD51C controls RAD51
recruitment to the processed DSB ends in the initial stages of HR.
(c) RAD51C also regulates resolution of recombination intermediates at the
later stages. (d) RAD51C is required for CHK2 activation and checkpoint
function. (e) FA core complex is activated and recruited by ATR kinase in
response to ICL lesion. (f) RAD51C appears to be part of the ICL repair
complex contributing to the ICL repair. Defect in the RAD51C HR function
and checkpoint regulation may cause FA-like disorder and cancer.
Tumor suppressor function of RAD51C
2033Recent studies indicate that the primary function of FA pathway is
to activate DNA damage signaling and ICL repair in the S-phase of
the cell cycle. First, the activation of the FA pathway through mono-
ubiquitination of FANCD2 and FANCI occurs in S-phase. Second,
during S-phase, monoubiquitinated FANCD2 and FANCI speciﬁcally
localizes with replication and repair foci containing BRCA1, BRCA2,
RAD51 and PCNA proteins (111,120,121). These proteins are re-
quired for the error-free replication of DNA and repair of damaged
DNA during replication by HR (106,108,122–124). Current studies
indicate that activation of the FA pathway occurs by ATR-dependent
phosphorylation of FANCI (Figure 2) (125–128). Following activa-
tion, the molecular mechanism by which FA pathway regulates DNA
repair process is poorly understood. However, there is evidence that
FANCD2 and FANCI (ID complex) facilitate translesion synthesis
and HR at the site of stalled/collapsed replication forks(124,127,129).
Although mammalian RAD51 paralogs were known to have a crit-
ical function in HR, genome maintenance and in the survival of the
organism, none of the RAD51 paralogs were known to be associated
with any human disorder. In a recent study, Vaz et al. (103) show
biallelic mutation in RAD51C leading to FA-like disorder. They iden-
tiﬁed homozygous missense mutation in the RAD51C gene in a con-
sanguineous family with multiple severe abnormalities characteristic
of FA. Children in the family showed congenital developmental ab-
normalities and, lymphocytes from patient showed increased sensi-
tivity to MMC, elevated chromosome breakage and pronounced G2
arrest in response to ICL damage, which are hallmarks of FA cells.
However, no hematological abnormalities and cancer were diagnosed
in these patients. Thus, authors classify it as an FA-like disorder and
assign RAD51C as FA-O, a 14th in the FA family of genes (103,130).
Interestingly, the levels of FANCD2 and its monoubiquitinated form
were not affected in these patients, suggesting a downstream defect in
the FA pathway (Figure 2). Sequencing of RAD51C exon 5 revealed
a homozygous missense mutation (G773A / R258H). Notably,
RAD51C arginine 258 residue is highly conserved in various organ-
isms including mice, hamster and chicken, implicating a crucial role
of this residue in HR.
The molecular mechanism by which RAD51C regulates HR and
ICL repair is poorly understood. Nonetheless, the Chinese hamster
RAD51C-deﬁcient irs3 and CL-V4B cells and RAD51C-knockout
chicken DT40 cells have served as excellent models to understand
the biology of RAD51C (56). Using these cells, it will be interesting
to study the role of RAD51C R258H in HR-mediated DSBR, in the
repair of ICLs, checkpoint function, chromosome segregation and
genome maintenance. These studies will provide new insights into
the development of an FA-like disorder due to a germline mutation in
RAD51C. Preliminary studies from our group indicate that RAD51C
R258H partially rescues the MMC hypersensitivity of CL-V4B cells
compared with WT RAD51C (K.S and G. N., unpublished results).
Indeed, Vaz et al. (103) found a similar phenotype with irs3 cells,
suggesting that RAD51C R258H is a hypomorphic mutant.
How RAD51C contributes to ICL repair, perhaps in collaboration
with FA proteins is not clear yet. Given the known functions of
RAD51C in HR and its ability to bind branched DNA and Y-junctions
(79), it is possible that RAD51C may be required for binding to ICLs
to activate the FA pathway. It is probably that the RAD51C-interacting
protein XRCC3 also may be involved in ICL recognition. Interest-
ingly, XRCC3 has been shown to interact with FANCG, FANCD1/
BRCA2 and FANCD2 in a newly identiﬁed complex (131). However,
it is not known whether RAD51C is also part of this complex. Fur-
thermore, an epistatic interaction between FA proteins and XRCC2
and XRCC3 has been reported, suggesting the involvement of addi-
tional RAD51 paralogs in FA pathway of ICL repair (131,132). Vaz
et al. (103) found that cellular levels of FANCD2 and its monoubi-
quitinated form were not affected in primary ﬁbroblasts from a patient
with RAD51C mutation, suggesting that RAD51C functions outside
the FA core complex (Figure 2). Conceivably, RAD51C may be es-
sential for recruiting RAD51 and other repair factors to initiate HR
during ICL repair. It is possible that the RAD51C hypomorphic mu-
tant found in FA-like disorder may be able to recognize ICLs to
activate FA pathway but is defective in HR during ICL repair. Further
investigations are required to test these hypotheses.
RAD51C as a novel cancer susceptibility gene
Breast cancer is the most predominant cancer among females and  5%
of all the reported breast cancer cases are due to inherited mutations in
BRCA1 and BRCA2 genes. Individuals affected with germline muta-
tion in BRCA1 and BRCA2 tumor suppressor genes also develop
ovarian cancer. Interestingly, analyses of tumors from these patients
reveal LOH at BRCA1 and BRCA2 gene loci with a loss of WTallele
and retention of disease predisposition allele (12,133). Genetic and
biochemical studies identify a role of BRCA1 and BRCA2 in HR-
mediated DSBR in mitotic and meiotic cells. BRCA1 localizes with
RAD51 in discrete nuclear foci in S and G2 phase mitotic cells, and
BRCA2 interacts with RAD51 stochiometrically (134,135). Further
studies show that BRCA1 and BRCA2 exist in a biochemical complex
and colocalize in somatic and meiotic cells (136). Like RAD51 and
BRCA1,BRCA2alsolocalizestothesitesofstalledreplicationforksin
response to hydroxyurea and ultraviolet irradiation (136). BRCA1 and
BRCA2 nullmicedieearly in development, and cells lacking BRCA1 or
BRCA2 reveal genome instability in the form of spontaneous chromo-
some breakage, severe aneuploidy and centrosome ampliﬁcation, sug-
gesting a role of BRCA1 and BRCA2 in HR and in the maintenance of
genome integrity (11,137–140). More direct evidence for the role of
BRCA1 and BRCA2 in HR came from studies using a reporter to
quantify HR in response to DSBs induced by I-SceI expression. Cells
lacking BRCA1 and BRCA2 display reduced HR ( 5 fold) compared
with WT cells (141,142).
BRCA1 has been shown to undergo phosphorylation at multiple
sites by ATM and ATR kinases. Mutation in two of these phosphoryla-
tion sites, Ser1423 and Ser1524 fails to correct the radiation hypersen-
sitivity of cells lacking BRCA1, suggesting that these phosphorylations
are crucial for DSBR (143).In addition, BRCA1 and ATR colocalizes in
response to replication stress induced by hydroxyurea and ultraviolet
treatment. Consistent with this observation, BRCA1 has been shown to
be phosphorylated by ATR at several sites including Ser1423 (144).
BRCA1-mutant cells exhibit an intact G1–S checkpoint but aredefective
in IR-induced G2–M checkpoint. In addition, BRCA1 phosphorylation
onSer1387 by ATMis requiredforactivation ofanintra-S-phase check-
point (145–147). Recent studies show that CHK2-mediated BRCA1
Ser988 phosphorylation is important for HR-mediated DSB repair by
suppressing microhomology-mediated non-homologous end joining
(148,149). Together these observations support the role of BRCA1 in
the coordination of checkpoint activation and HR in response to DNA
damage and in maintaining genome stability.
Genetic and biochemical studies indicate that the role of BRCA1
and BRCA2 in HR appears to be in the regulation of RAD51 function.
RAD51 was identiﬁed as the ﬁrst protein to interact with BRCA2
(150). The well-conserved BRC repeats in the central part of BRCA2
are essential for direct interaction with RAD51, and this association is
critical for HR (11,139,140,151). BRCA2 has been thought to be
required for the mobilization of RAD51 into the nucleus and to sites
of DNA damage. Consistently, BRCA2-deﬁcient cells fail to show
RAD51 nuclear foci formation in response to DNA damage (152).
BRCA2 C-terminal domain interacts with another highly conserved
protein DSS1 (153), which is required for efﬁcient HR in vivo
(154,155). The Ustilago maydis BRCA2 homolog, Brh2 contains only
one BRC domain, and Brh2 together with DSS1 efﬁciently catalyzes
RAD51 polymerization onto RPA-coated double-stranded DNA–
ssDNA junction (156). Consistent with this observation, BRC3 and
BRC4 repeats and DNA-binding domain of human BRCA2 (BRC3/4-
DBD) has been shown to stimulate presynaptic assembly of RAD51
onto ssDNA (157). Furthermore, recent studies demonstrate that full-
length BRCA2 facilitates RAD51 ﬁlament assembly onto RPA-coated
ssDNA (158–160). These results clearly suggest recombination me-
diator function of BRCA2 in RAD51-promoted HR.
BRCA1 and BRCA2 are high penetrance breastcancer susceptibility
genes that show .10-fold increase in the risk of breast cancer.
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2034Screening of mutations identiﬁed additional breast cancer suscepti-
bility genes such as ATM, CHEK2, BACHI (BRIP1) and PALB2 (161).
These genes are known to have role in genome maintenance and HR,
and mutation in these genes are rare and, confer intermediate risk
of breast cancer. In a striking recent study, Meindl et al. report an
increase in the risk of breast and ovarian cancer for monoallelic
germline mutations in RAD51C (104,162). Their study provides the
ﬁrst evidence to show that RAD51C is a cancer susceptibility gene.
They identiﬁed a total of 14 mutations in RAD51C, which include
base insertions, splice site mutations and missense mutations. Among
10 missense mutations, retroviral expression of human RAD51C
G125V and L138F was unable to rescue the hypersensitivity of
DRAD51C chicken DT40 cells to MMC. Consistent with their obser-
vation, expression of RAD51C G125V and L138F missense mutants
did not restore normal RAD51 foci formation in the RAD51C mutant
ﬁbroblasts, suggesting an obvious HR defect in these RAD51C mis-
sense mutants. Screening of the remaining RAD51C missense mutants
in cell survival studies revealed that, four of the missense mutations,
RAD51C D159N, G264S, T287A and R366Q partially rescued the
MMC sensitivity of DT40 cells that lack RAD51C. In contrast, the
remaining missense mutants behaved similar to WT RAD51C in
MMC sensitivity assay.
The RAD51C amino acid residues that were found mutated in
patients susceptible to breast and ovarian cancer are highly conserved
inchicken, mouse and Chinese hamster cells, suggestinga critical role
of these residues in HRand tumor suppressor function. Using RAD51C-
deﬁcient hamster and chicken DT40 cells, it will be interesting to test
whether these hypomorphic mutants are defective in HR, DNA damage
signaling, centrosome maintenance, and chromosome segregation to
gain insights into breast and ovarian cancer susceptibility.
The pedigree analyses by Meindl et al. (104) clearly indicate that,
like BRCA1 and BRCA2, RAD51C is a high penetrance breast cancer
susceptibility gene. The gross chromosomal rearrangements observed
with BRCA gene mutation is probably due to defect in the repair of
DSBs and daughter strand gaps by HR mechanism (163,164). The
chromosomal abnormality with BRCA gene mutation is thought to
trigger accumulation of mutations and altered expression of onco-
genes leading to tumor progression. Indeed, gross chromosomal re-
arrangements are the most frequent type of lesions found in human
tumors that lead to the loss of tumor suppressor loci (139). The
RAD51C HR dysfunction may similarly cause gross chromosomal
rearrangements leading to breast and ovarian cancer susceptibility
(Figure 2). In agreement with this, chicken DT40 and hamster cells
with a RAD51C mutation exhibit spontaneous chromosomal aberra-
tions similar to BRCA genes (56,63–65). Together, these observations
support that RAD51C is a caretaker and tumor suppressor gene.
Conclusion and future direction
Despite our understanding of the role of RAD51C in initial and late
stages of HR, the underlying mechanism(s) remains obscure. The fact
that accumulation of RAD51C at the sites of DSBs is dependent on
ATM suggests that phosphorylation of RAD51C by ATM may be one
mechanism by which RAD51C assists RAD51 function (Figure 2).
Further investigation is required to test this hypothesis. Helicases and
nucleases are required for the resolution of HJ structures or other type
of recombination/repair intermediates. The lack of any known nucle-
ase or helicase motifs in the RAD51C suggests that the role of
RAD51C in resolving HJ structures in the late stages of HR may be
indirect. It will be interesting to test whether RAD51C interacts with
any of the helicases or nucleases and stimulates its activity.
The RAD51C-dependent CHK2 activation reveals a novel role
of RAD51C in DNA damage response and checkpoint function
(88). The recent reports of Vaz et al. (103) and Meindl et al. (104)
provide the ﬁrst evidence of RAD51C mutation leading to rare human
genetic disorder and cancer . These observations clearly indicate that
RAD51C is multifunctional (Figure 2). RAD51C mutations that were
identiﬁed in FA and, breast and ovarian cancer patients reveal that
there are independent HR functions of RAD51C in FA and BRCA
pathway (130,162). Consistent with this hypothesis, partial loss of
RAD51 foci formation was observed in FA cells with RAD51C mu-
tation (103), suggesting that RAD51C-regulated HR during ICL re-
pair may be compromised. RAD51C may also regulate HR outside
the ICL repair, which is further supported by the fact that RAD51C
deﬁciency shows severe HR defect ( 10-fold), measured by HR re-
porter and RAD51 foci formation (34,63–65,165,166). In addition,
genetic knockout of RAD51C is embryonically lethal (70). Further
investigation is necessary to understand the independent roles of
RAD51C in FA and BRCA pathway.
As discussed above, mutation in BRCA1 and BRCA2 causes famil-
ial breast and ovarian cancer. These genes are essential for HR and in
particular BRCA2 is known to act as recombination mediator helping
RAD51 polymerization onto ssDNA. RAD51C also has been impli-
cated as a recombination mediator despite the lack of molecular
mechanism. It will be interesting to study whether RAD51C and
BRCA2 act in a common pathway or independently to regulate
RAD51-mediated HR. The LOH that was observed at RAD51C loci
in breast cancer patients suggest a critical role of RAD51C in tumor
suppressor function. This is further supported by the fact that mice
knockout of RAD51C is embryonically lethal and show suppression of
tumor formation similar to TP53 (167). The identiﬁcation of RAD51C
as a high penetrance breast and ovarian cancer susceptibility gene
provides a clue that perhaps mutation in other RAD51 paralogs may
cause cancer susceptibility. Indeed, a multistage genome-wide asso-
ciation study identiﬁes that RAD51B mutation can lead to breast
cancer risk (168).
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